跳至主要内容
临床试验/NCT03076034
NCT03076034进行中(未招募)不适用

Utility of Cortical Bone Tissue Properties in the Assessment of Fracture Risk

Beth Israel Deaconess Medical Center2 个研究点 分布在 1 个国家目标入组 190 人开始时间: 2015年1月26日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
190
试验地点
2
主要终点
Cortical bone tissue properties by reference point indentation

研究概览

简要总结

The objective of this study is to determine whether a new minimally invasive method for in vivo measurement of cortical bone tissue properties can identify those who are at risk for fragility fractures of the hip and radius. The investigators hypothesis is that women with fragility fractures of the hip and radius have altered cortical bone tissue properties compared to non-fracture controls independent of standard clinical tests, such as bone mineral density (BMD) by dual-energy x-ray absorptiometry (DXA).

详细描述

The objective of this study is to determine whether a new minimally invasive method for in vivo measurement of cortical bone tissue properties can identify those who are at risk for fragility fractures of the hip and radius. The investigators hypothesis is that women with fragility fractures of the hip and radius have altered cortical bone tissue properties compared to non-fracture controls independent of standard clinical tests, such as BMD. To test these hypotheses, The investigators propose two aims:

Aim 1: Compare cortical bone tissue properties as assessed in vivo by reference point indentation in women with hip fractures and non-fracture controls.

The investigators will compare cortical bone tissue material properties, as assessed by novel in vivo indentation at the mid-tibia in postmenopausal women with recent hip fractures (n) and age-similar controls without fractures (n=). In addition to in vivo indentation measurements, The investigators will assess hip and spine BMD by DXA; as well as other factors that may influence risk of fractures (e.g, vit D status, medication use and physical activity). Hypotheses: Postmenopausal women with hip fractures will have worse bone tissue material properties compared to non-fracture controls even after adjustment for BMD and other potential confounders.

Aim 2: Compare cortical bone tissue properties as assessed in vivo by reference point indentation in women with distal radius fractures to non-fracture controls.

The investigators will compare cortical bone tissue material properties, as assessed by novel in vivo indentation at the mid-tibia in postmenopausal women with recent distal radius fractures (n) and age-similar controls without fractures (n=). In addition to in vivo indentation measurements, The investigators will assess hip and spine BMD by DXA; as well as other factors that may influence risk of fractures (e.g, vit D status, medication use and physical activity). Hypotheses: Postmenopausal women with distal radius fractures will have worse bone tissue material properties compared to non-fracture controls even after adjustment for BMD and other potential confounders.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
50 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Women with hip and wrist fractures within 2 weeks of presentation
  • Non-fracture controls

排除标准

  • Unable to undergo BMD by DXA or high-resolution peripheral quantitative computed tomography (HR-pQCT)
  • History of skeletal metastasis, primary hyperparathyroidism, Paget's disease, multiple myeloma
  • Treatment with bisphosphonate, estrogen (within previous 3 years), teriparatide therapy, calcitonin, selective estrogen receptor modulator (SERMs,within previous 3 years)
  • Use of glucocorticoids continuously for more than 3 months, use of anticonvulsants
  • Prior fracture in adulthood (>age 18) for healthy controls
  • Amendment to protocol added Arm 2, to include males >50 years with otherwise similar eligibility criteria.

结局指标

主要结局

Cortical bone tissue properties by reference point indentation

时间窗: Day 1

Osteoprobe measurement

Bone mineral density (BMD) by dual-energy x-ray absorptiometry (DXA)

时间窗: Day 1

DXA at the hip and spine

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Tamara Rozental

Associate Professor, Harvard Medical School

Beth Israel Deaconess Medical Center

研究点 (2)

Loading locations...

相似试验

招募中
不适用
Comparison of two different surgical approaches to decompress lumbar spinal nerves in patients with narrow lumbar spinal canal and instability
ISRCTN99263604Medical University of Innsbruck154
招募中
4 期
Comparison Of Bone Thickness In Patients Treated With Special (Damon)Brackets and Normal(conventional) Brackets Using CBCT.
CTRI/2018/04/013193Dr Kranthi Kiran Tatikonda
已完成
3 期
Study of the Effect of Once a Week Risedronate on the Microstructure of Tibia and Radius Using a New Scanning MethodOsteopenia
NCT00386360Warner Chilcott161
进行中(未招募)
1 期
A Non-invasive Evaluation of Bone Microarchitecture Modification in Osteopenic Postmenopausal Women by 3D Peripheral Quantitative Computed Tomography: A 12 Month, Multicenter, Double-blind, Randomized, Parallel Group Study Comparing Weekly Oral Risedronate 35 mg and PlaceboOsteoporosis is a systemic skeletal disorder characterized by low bone mass and micro-architectural deterioration of bone tissue leading to enhanced bone fragility and susceptibility to fracture. Postmenopausal women with a diagnosis of osteopenia (T score between –2.5 and –1.0 based on the World Health Organization classification) may also be at risk of fracture.MedDRA version: 7.0 Level: PT Classification code 10031285
EUCTR2005-003033-41-GBProcter & Gamble Technical Centres Limited156
进行中(未招募)
不适用
A Non-invasive Evaluation of Bone Microarchitecture Modification in Osteopenic Postmenopausal Women by 3D Peripheral Quantitative Computed Tomography: A 12 Month, Multicenter, Double-blind, Randomized, Parallel Group Study Comparing Weekly Oral Risedronate 35 mg and Placebo
EUCTR2005-003033-41-DEProcter & Gamble Technical Centres Limited156
Utility of Cortical Bone Tissue Properties in the... | 临床试验